Skip to main content
. 2018 Aug 14;27(20):3612–3626. doi: 10.1093/hmg/ddy259

Figure 8.

Figure 8

A proposed biomarker panel for genetic diagnosis and developing treatments. (A) Signature genes, identified by stringent expression filtering (Cntl < 10 CPM, Hurler > 30 CPM and DE > 16-fold) and based on pathways investigated in Figures 47. Genes indicated in bold were validated by qRT-PCR. (B) Validation of selected top candidate signature genes by qRT-PCR.